Article Details

Lecanemab trial 'pivotal' for other therapy developers targeting Alzheimer's disease

Retrieved on: 2022-10-06 21:03:43

Tags for this article:

Click the tags to see associated articles and topics

Lecanemab trial 'pivotal' for other therapy developers targeting Alzheimer's disease. View article details on hiswai:

Excerpt

Lecanemab is an anti-amyloid beta (Aβ) protofibril antibody for the ... on first generation treatments such as anti-Aβ monoclonal antibodies like ...

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up